Sutro Biopharma, Inc. (STRO)
NASDAQ·Healthcare·Biotechnology
$28.72
+1.93%
Mkt Cap $212.66M
Analyst Ratings
No recent rating data.
Price Target (16 analysts)
$50.75
Range $43.00 – $60.00
Implied Upside
+76.7%
Consensus $50.75 vs current $28.72
NASDAQ·Healthcare·Biotechnology
$28.72
+1.93%
Mkt Cap $212.66M
No recent rating data.
Price Target (16 analysts)
$50.75
Range $43.00 – $60.00
+76.7%
Consensus $50.75 vs current $28.72